Does Skyla Insertion Timing Impact Bleeding?
Sponsor: Rutgers, The State University of New Jersey
Listed as NCT03074903, this observational or N/A phase trial focuses on Vaginal Bleeding and remains completed. Sponsored by Rutgers, The State University of New Jersey, it has been updated 10 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Feb 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Feb 2020 [monthly]
Completed
▶ Show 5 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Oct 2017 — Mar 2018 [monthly]
Active Not Recruiting NA
-
Jul 2017 — Oct 2017 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2017 — Jul 2017 [monthly]
Recruiting NA
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rutgers, The State University of New Jersey
For direct contact, visit the study record on ClinicalTrials.gov .